Physical Training and Cardiac Rehabilitation in Heart Failure Patients

Cesare de Gregorio1

  • 1Department of Clinical and Experimental Medicine - Cardiology Unit, University Hospital Medical School "Gaetano Martino", Messina, Italy. cdegregorio@unime.it.

Insights

Cardiac rehabilitation (CR) is crucial for cardiovascular disease (CVD) patients but underutilized. Combining exercise with risk factor control improves outcomes and reduces hospitalizations for heart failure.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Exercise Physiology

Background:

  • Despite advances in cardiovascular disease (CVD) treatments, patient enrollment in cardiac rehabilitation (CR) remains low.
  • Increased survival from acute events leads to a growing global burden of chronic heart failure.
  • Secondary prevention strategies are underutilized, even in high-income nations, highlighting a gap in patient care.

Purpose of the Study:

  • To review current evidence on cardiac rehabilitation (CR) training modalities for heart failure patients.
  • To discuss the potential benefits of CR in managing heart failure and improving patient outcomes.
  • To emphasize the importance of integrated approaches combining exercise and risk factor control.

Main Methods:

  • Review of recent scientific literature on exercise-based cardiac rehabilitation.
  • Analysis of training models and their effects on cardiovascular patients.
  • Discussion of confounding factors such as lifestyle, psychosocial challenges, and patient compliance.

Main Results:

  • Exercise-based training is a fundamental aspect of primary and secondary CVD prevention.
  • Combined interventions including regular exercise improve metabolic and hemodynamic conditions.
  • Evidence suggests CR benefits extend to heart failure patients, despite varied training protocols.

Conclusions:

  • Cardiac rehabilitation (CR) is essential for managing cardiovascular disease (CVD) and heart failure.
  • Integrated strategies combining medical treatment, exercise, and risk factor control are vital.
  • Further research into standardized CR protocols may enhance its effectiveness and patient adherence.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
966
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
402
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
369